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Arrhythmogenic Calmodulin Mutations Disrupt Intracellular
Cardiomyocyte Ca2+ Regulation by Distinct Mechanisms
Guo Yin, MS;* Faisal Hassan, BS;* Ayman R. Haroun, MS; Lisa L. Murphy, BS; Lia Crotti, MD, PhD; Peter J. Schwartz, MD;
Alfred L. George, Jr, MD; Jonathan Satin, PhD
Background-—Calmodulin (CaM) mutations have been identified recently in subjects with congenital long QT syndrome (LQTS) or
catecholaminergic polymorphic ventricular tachycardia (CPVT), but the mechanisms responsible for these divergent arrhythmia-
susceptibility syndromes in this context are unknown. We tested the hypothesis that LQTS-associated CaM mutants disrupt Ca2+
homeostasis in developing cardiomyocytes possibly by affecting either late Na current or Ca2+-dependent inactivation of L-type
Ca2+ current.
Methods and Results-—We coexpressed CaM mutants with the human cardiac Na channel (NaV1.5) in tsA201 cells, and we used
mammalian fetal ventricular cardiomyocytes to investigate LQTS- and CPVT-associated CaM mutations (LQTS- and CPVT-CaM).
LQTS-CaM mutants do not consistently affect L-type Na current in heterologous cells or native cardiomyocytes, suggesting that the
Na channel does not contribute to LQTS pathogenesis in the context of CaM mutations. LQTS-CaM mutants (D96V, D130G, F142L)
impaired Ca2+-dependent inactivation, whereas the CPVT-CaM mutant N54I had no effect on Ca2+-dependent inactivation. LQTS-
CaM mutants led to loss of Ca2+-transient entrainment with the rank order from greatest to least effect: CaM-D130G~CaM-
D96V>>CaM-F142L. This rank order follows measured Ca2+-CaM affinities for wild-type and mutant CaM. Acute isoproterenol
restored entrainment for CaM-130G and CaM-D96V but caused irreversible cytosolic Ca2+ overload for cells expressing a CPVT-
CaM mutant.
Conclusions-—CaM mutations associated with LQTS may not affect L-type Na+ current but may evoke defective Ca2+-dependent
inactivation of L-type Ca2+ current. ( J Am Heart Assoc. 2014;3:e000996 doi: 10.1161/JAHA.114.000996)
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C ongenital long QT syndrome (LQTS) and catecholamin-ergic polymorphic ventricular tachycardia (CPVT) are 2
genetic disorders of heart rhythm that may present during
childhood and cause life-threatening cardiac arrhythmias.1
The molecular mechanisms underlying arrhythmia suscepti-
bility have been inferred from studies of mutant gene
products, which are largely ion channels or channel regula-
tors. In LQTS, loss of function in potassium channels or gain
of function in either Na or Ca2+ channels represent the major
molecular mechanisms. In contrast to disturbances in plasma
membrane ion channel function, CPVT arises from disordered
intracellular Ca2+ regulation, most frequently because of
mutation of the ryanodine receptor Ca2+-release channel of
the sarcoplasmic reticulum (SR). These advances have
improved our understanding of arrhythmogenesis in general
and have revealed new therapeutic targets.
Recently, recurrent cardiac arrest in infants with a
severe form of LQTS was associated with mutations in
CALM1 (D130G, F142L) or CALM2 (D96V), 2 genes
encoding the ubiquitous Ca2+-signaling protein calmodulin
(CaM).2 Independently, 2 distinct CaM mutations (N54I,
N98S) were discovered in subjects with a CPVT-like
syndrome although one of these mutations (N98S) has
also been identified in a subject with LQTS.3 Most of the
mutations affect conserved amino acid residues that are
known to participate in Ca2+ binding or in energetic
coupling of ion binding to CaM activation. Biochemical
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studies revealed that most CaM mutations, except N54I,
cause reduced Ca2+-binding affinity.2,4 However, the cellular
basis for arrhythmogenesis in the setting of CaM mutations
has not been elucidated.
CaM controls a large number of enzymes, ion channels,
and other proteins.5 In cardiomyocytes, key CaM-interacting
proteins include those critically involved in beat-to-beat Ca2+
homeostasis. CaM is prebound to the cardiac L-type Ca2+
channel (LTCC), where it senses local Ca2+ influx and
cytosolic Ca2+. The complex of Ca2+-CaM promotes rapid
inactivation of LTCC Ca2+ current (ICa,L).
6 This process,
known as Ca2+-dependent inactivation (CDI), is a major
determinant of cardiac excitability.7 Engineered CaM with
carboxyl lobe (C-lobe) mutations abrogating C-lobe Ca2+
binding attenuated CDI and prolonged action potential (AP)
duration.7 The majority of the z-line CaM also binds to
ryanodine receptor 2 (RyR2),8 and CaM inhibits RyR2
openings independent of Ca2+ concentration.9,10 Disrupting
CaM-RyR2 interaction has multiple effects including
increased opening of RyR2, diminished ICa,L, and increased
cytosolic Ca2+ at negative membrane potentials, creating a
molecular substrate for arrhythmogenic triggers.11
Consequently, at the cellular level, we anticipate that CaM
mutants targeting CDI will have distinct effects from those
disrupting CaM-RyR2 interactions. Most recently, CPVT-CaMs
were shown to cause arrhythmogenic Ca2+ disturbances in
permeabilized cardiomyocytes that were distinct from LQT-
CaM–provoked alterations.12
In this study, we examined the effects of LQTS-associ-
ated CaM mutations on Na and Ca2+ channel currents to
elucidate cellular and molecular mechanisms underlying
arrhythmia predisposition. We found that CaM mutations
had inconsistent effects on Na channels but caused
impaired CDI of ICa,L in cardiomyocytes and dysregulation
of cytosolic Ca2+. In parallel, we examined the impact of the
CPVT-associated mutation, N54I, on ICa,L and observed no
direct effects on LTCC current in cardiomyocytes; however,
this mutation caused significant abnormalities in Ca2+
homeostasis. Our findings implicate different molecular
substrates for arrhythmogenesis associated with CaM
mutations.
Methods
All experimental procedures and protocols involving animals
were approved by the animal care and use committee of the
University of Kentucky and conformed to the NIH Guide for
Care and Use of Laboratory Animals. Isolated fetal ventricular
cardiomyocytes (FVM) were prepared as previously
described,13 except embryonic day 18 to 19 pregnant dams
were used.
Mutagenesis of Calmodulin
Mutant CaMs were engineered by making one of the following
amino acid substitutions: N54I, D96V, N98S, D130G, or
F142L. A mammalian expression plasmid was used to drive
expression of wild-type (WT) or mutant CaM by the immediate
early CMV promoter along with the coding region for either
green fluorescent protein or CD8 preceded by the IRES2
element as cotransfection markers.
Heterologous Expression of Human NaV1.5 With
Calmodulin
Plasmids encoding recombinant human cardiac Na channel
isoforms (NaV1.5) were described previously.
14 For studies of
Na channel function, WT cardiac Na channel cDNA (0.5 lg)
and WT or mutant CaM (D130G, D96V, and F142L) cDNA
(0.5 lg) in vectors encoding the cotransfection marker CD8
were transiently transfected into tsA201 cells using FuGene
HD (Roche Diagnostics, Indianapolis, IN), then incubated for
48 hours at 37°C prior to electrophysiological measurements.
Dynabeads-CD8 (Invitrogen Life Technologies, Carlsbad, CA)
were added to cell culture media according to manufacturer’s
instructions to mark cells transfected successfully. Cells
selected for patch clamp recordings exhibited CD8 expression
with Dynabeads attached to the cell surface and were easily
distinguishable from non–CD8-expressing cells.
Fetal Ventricular Myocyte Tissue Harvest or Cell
Culture
Hearts of embryonic day 18 to 19 (a fetal stage) mouse (ICR
outbred strain; Harlan Laboratories) were dissected free of
connective tissues, and ventricles were separated from atria.
Cells were enzymatically dispersed and cultured as previously
described.15 Briefly, about 10 fetuses were minced and
quickly transferred to nominally Ca2+-free digestion buffer
containing 0.5 mg/mL collagenase (type II; Worthington
Biochemical Corporation) and 1 mg/mL pancreatin for two
15-minute cycles. Digested tissue yielded a large fraction of
single spontaneously beating cells in culture media consisting
of DMEM plus 10% FBS. Cells were transfected in 24-well
plates using Lipofectamine transfection reagent (Invitrogen
Life Technologies). Cells were transfected with plasmids given
above and used 24 to 48 hours after transfection. FVM were
selected for study based on enhanced green fluorescent
protein fluorescence unless otherwise noted.
Electrophysiology
Na currents were recorded at room temperature using
the whole-cell patch clamp technique as described pre-
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viously.14,16 The extracellular bath solution contained the
following (in millimoles per liter): 140 NaCl, 4 KCl, 1.8 CaCl2, 1
MgCl2, 10 HEPES, and 10 glucose, pH 7.35 (adjusted with
NaOH). The low-Ca2+ intracellular pipette solution contained
the following (in millimoles per liter): 10 NaF, 100 CsF, 20
CsCl, 20 BAPTA, 10 HEPES, 10 glucose, pH 7.35 (adjusted
with CsOH). The high-Ca2+ (~1-lmol/L free) intracellular
pipette solution contained the following (in millimoles per
liter): 10 NaF, 100 CsF, 20 CsCl, 1 BAPTA, 0.9 CaCl2, 10
HEPES, 10 glucose, pH 7.35 (adjusted with CsOH).17 Osmo-
larity was adjusted to 310 mOsm/L with sucrose for the bath
solution and 300 mOsm/L for pipette solution. Data were
acquired with an Axopatch 200B patch clamp amplifier and
pClamp 10.2 software. Tetrodotoxin-sensitive persistent cur-
rent was determined with 200-ms depolarization to 30 mV
as the average current recorded between 190 and 200 ms
and reported as a percentage of peak current following digital
subtraction of currents recorded in the presence and absence
of 30 lmol/L tetrodotoxin (Tocris Biosciences, Ellisville, MO).
All data were analyzed with pClamp 10.2 (Axon Instruments,
Inc, Sunnyvale, CA) and plotted using SigmaPlot 10 (IBM Corp,
Armonk, NY) software. Unless otherwise noted, statistical
comparisons were made by using a 1-way ANOVA and
Bonferroni correction to WT NaV1.5 coexpressed with WT
CaM. Statistical significance was assumed for P<0.05. Results
are presented as meanSEM for all pooled data.
FVM ICa,L recordings were recorded in the whole-cell
configuration of the patch clamp technique as previously
described.18 All recordings were performed at room temper-
ature (20 to 22°C). The pipette solution consisted of (in
millimoles per liter): 125 Cs-methanesulfonate, 15 TEA-Cl, 1
MgCl2, 0.5 EGTA, 5 HEPES, pH 7.2. Bath solution contained
(in millimoles per liter):150 NMDG, 2.5 CaCl2, 1 MgCl2, 10
glucose, 10 HEPES, 5 4-aminopyridine, pH7.2. Activation
voltage dependence parameters were obtained by fitting the
current-voltage slope conductance transform to a Boltzmann
distribution of the form G(V)=Gmax/(1+exp(V½/k)) in which
Gmax is the maximal conductance and V½ is the activation
midpoint. Results are presented as meanSEM for all pooled
data.
Cytosolic Ca2+ Imaging
Cardiac myocytes were loaded with 2 lmol/L fura-2-AM for
10 minutes in a 5% CO2 incubator and then de-esterified in
Tyrodes (140 NaCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES [free acid],
5.4 KCl, 10 glucose, pH 7.4, NaOH) solution for ~20 minutes.
Field-stimulated Ca2+ transients were recorded from the
annulus of the photometry tube focused on a single cell or a
cell cluster. All recordings were performed at 20 to 22°C. The
cells were excited with light of 340-nm and 380-nm
wavelengths. The images obtained at 340 and 380 nm were
divided pixel by pixel, and the ratio data were reported. Data
were collected and analyzed with IonOptix (Milton, MA)
hardware and software. Additional offline transient analysis
was performed with custom routines written in MatLab
(Northampton, MA). Exponential fitting was performed using
pClamp 9.2 (Axon Instruments, Union City, CA). The function
used for exponential fitting of caffeine-induced Ca2+ transient
relaxations was f(t)=Ai9exp (t/si)+C.
Statistical Analysis
Data were analyzed for Figures 5C, 6B, 7B, and 7D with the
chi-square test. Figure 9A was analyzed with 1-way ANOVA
with Dunn’s multiple comparison test. Figure 9A and the
remaining data analysis passed the D’Agostino and Pearson
test and the Shapiro-Wilk test for normality, and tests of
statistical difference for the remaining data were performed
using the t test with statistical significance correction of
multiple comparisons and a=0.05 using the Holm-Sidak
method in GraphPad Prism version 6.0 for Windows (Graph-
Pad Software, La Jolla, CA).
Results
Effect of CaM Mutants on Cardiac Na Channels
Because CaM is known to regulate cardiac Na channel
inactivation and a specific defect in Na channel inactivation
(increased persistent Na current) occurs in LQTS,19 we
investigated the effects of LQTS-CaM mutants on heterolo-
gously expressed NaV1.5 as well as on native Na current. We
performed heterologous coexpression of WT or mutant CaM
with human NaV1.5 in tsA201 cells and then measured
electrophysiological properties of the expressed channels.
When recording Na current with a nominally Ca2+-free
intracellular solution, we did not observe differences in the
level of persistent Na current (expressed as a percentage of
peak current) for any of the CaM mutations compared with WT
CaM. Consequently, we repeated these experiments with
elevated intracellular calcium (~1 lmol/L free Ca2+) to
provide a saturating concentration of Ca2+ to promote binding
of CaM to NaV1.5.
2,17 Furthermore, because of the early age
of onset of LQTS in the reported probands, we also tested the
effects of CaM mutations on a fetal and neonatal-expressed
NaV1.5 splice variant.
14 Cells coexpressing CaM-D130G with
fetal NaV1.5 exhibited 7.5-fold larger persistent Na current
(1.50.4%) compared with cells coexpressing the fetal splice
variant with WT CaM (0.20.1%; P<0.05) when recordings
were made with high intracellular calcium (Figure 1A). This
greater level of persistent current was not observed when
CaM-D130G was coexpressed with the canonical (adult
expressed) splice isoform of NaV1.5 or with low intracellular
DOI: 10.1161/JAHA.114.000996 Journal of the American Heart Association 3
Calmodulin Mutations Associated With Arrhythmias Yin et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 at University of Kentucky--Lexington on February 16, 2016http://jaha.ahajournals.org/Downloaded from 
calcium (Table 1). In contrast, cells coexpressing fetal or
canonical NaV1.5 splice isoforms with either CaM-D96V or
CaM-F142L did not exhibit abnormal levels of persistent Na
current under high calcium conditions (Table 1). Other Na
channel properties including conductance-voltage relation-
ship, voltage dependence of steady-state inactivation, inacti-
vation kinetics, and recovery from inactivation were largely
unaffected by CaM mutants (Table 2). Furthermore, expres-
sion of CaM-D130G in mouse FVM did not evoke detectable
differences in the level of persistent Na current compared
with cells transfected with WT CaM (Figure 1B). Given the
inconsistent effect of CaM mutants on heterologous and
native Na current, we concluded that NaV1.5 dysfunction was
not the major cause of LQTS in the setting of CaM mutations.
CDI is Slowed by LQTS-CaM But Not by a CPVT-
Associated CaM Mutant
We tested the hypothesis that LQTS-CaM mutations with
impaired C-domain Ca2+ affinity will slow ICa,L decay in a
native cardiomyocyte environment due to impaired CDI.7
Figure 2A illustrates representative current sweeps normal-
ized to peak current for FVM expressing exogenous WT CaM
superimposed on traces from cells expressing each of the
LQTS-CaM mutants. All LQTS-CaM mutants slow ICa,L decay
with the 2 relatively low Ca2+ Kd CaM-mutants with altered
highly conserved aspartic acids that directly chelate the Ca2+
ion, showing relatively greater effect2 (Figure 2). Current
density and voltage dependence of current activation were
Table 1. Persistent Sodium Current in Cells Expressing WT or
Mutant CaM
Persistent Current % n
NaV1.5+apo WT* CaM 0.30.2 4
NaV1.5+apo CaM-D130G 0.20.1 4
NaV1.5+WT CaM 0.30.1 5
NaV1.5+CaM-D130G 0.20.1 5
NaV1.5+CaM-D96V 0.20.1 7
NaV1.5+CaM-F142L 0.10.1 4
Fetal NaV1.5+apo WT CaM 0.40.1 6
Fetal NaV1.5+apo CaM-D130G 0.60.2 7
Fetal NaV1.5+WT CaM 0.20.1 9
Fetal NaV1.5+CaM-D130G 1.50.4†,‡ 13
Fetal NaV1.5+CaM-D96V 0.40.1 8
Fetal NaV1.5+CaM-F142L 0.60.5 8
CaM indicates calmodulin; WT, wild type.
*apo WT CaM is Apocalmodulin (apo WT CaM is Ca2+-free CaM; WT refers to the disease-
associated sites identified in the probands2).
†P<0.05 compared to fetal NaV1.5+WT CaM.
‡P<0.05 compared to fetal NaV1.5+WT CaM with 10 lmol/L KN-93.
Data compared using Kruskal-Wallis 1-way ANOVA and Dunn’s Test.
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Figure 1. Long QT syndrome (LQTS) CaM mutation effects on persistent Na current are limited to a single
splice variant of NaV1.5 and a single CaM mutation. A, CaM-D130G evoked increased persistent sodium
current with fetal NaV1.5. Averaged tetrodotoxin-sensitive currents were normalized to the peak current
measured at 30 mV during a 200-ms depolarization recorded under high intracellular Ca2+ concentration
(see Methods). The inset represents the same data plotted on an expanded vertical scale. Summary data
are provided in Table 1. B, CaM-D130G has no significant effect on persistent Na current in fetal ventricular
cardiomyocytes. Tetrodotoxin-sensitive currents were normalized to the peak current measured at 30 mV
during a 300-ms depolarization recorded under high intracellular Ca2+ concentration (see Methods). The
inset represents the same data plotted on an expanded vertical scale. CaM indicates calmodulin; WT, wild
type.
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not different between FVM expressing WT or LQTS-CaM
mutants (Figure 3; Table 3). In contrast, the CPVT-association
CaM mutation N54I did not significantly affect CDI (Figure 4).
These data suggest that attenuated CDI and resulting slower
ICa,L decay can contribute to mutant CaM-associated LQTS
but not CPVT.
Rate Dependence of Entrainment to Field
Stimulation
Field stimulation of FVM causes a Ca2+-induced Ca2+ release
that follows a fire-diffusion-fire paradigm qualitatively similar
to that of mature cardiomyocytes.20 Figure 5A illustrates
representative Ca2+ transients from FVMs expressing either
WT or mutant CaM continuously paced from quiescence to
2 Hz. For cells expressing WT CaM, there was a synchronous
entrainment of field stimulation to Ca2+ transient (eg, 1:1
ratio; Figure 5A, top panel). Expression of CaM-F142L does
not compromise entrainment of Ca2+ transients at low
stimulation frequencies. The lower Ca2+-affinity mutations
CaM-D96V and CaM-D130G show frequent loss of entrain-
ment, as shown by the presence of 2:1 pacing block (eg, 2
stimuli for 1 transient; Figure 5B). The loss of entrainment
observed for LQTS-CaM mutants summarized as “number of
escapes” follows the rank order of Ca2+-CaM affinity, whereby
cardiomyocytes expressing the weaker Ca2+-affinity CaM
mutants escaped from pacing at progressively lower frequen-
cies (Figure 5C).
We categorized the Ca2+ transient phenotypes into those
displaying alternans, and those exhibiting slower Ca2+
reuptake manifested as smaller amplitude, slower decaying,
and elevated diastolic levels (Figure 6). The prevalence of
pathological Ca2+-transient phenotypes tracks with the rank
order of Ca2+-CaM affinity. The lowest affinity CaM mutations,
D96V and D130G, uniquely displayed overload phenotypes
(defined as diastolic Ca2+ >1 standard deviation above the
WT-CaM diastolic fluorescence level), and cells expressing
D96V and D130G also show a preponderance of reuptake
anomalies (Figure 6). In summary, LQTS-CaM mutants induce
arrhythmogenic activity in developing ventricular cardiomyo-
cytes. The severity of the dysfunction induced by various
LQTS-CaM mutations tracks with reported Ca2+-CaM affini-
ties.2 In contrast, the CPVT-CaM mutant N54I has near normal
Ca2+ affinity,4 but myocytes expressing this mutant exhibited
a marked inability to be paced by field stimulation (Figure 7A
and 7B). All N54I cardiomyocytes tested displayed patholog-
ical Ca2+ transients with 1-Hz pacing, with the majority
showing alternans (Figure 7C and 7D). These findings indicate
that disrupted Ca2+-transient entrainment is a common
disease-associated end point, despite the unique effect of
LQTS-CaM slowing of CDI.
LQTS-CaM Mutations Perturb Ca2+ Handling
We investigated whether elevation of cytosolic Ca2+ could
drive the loss of entrainment induced by LQTS-CaM mutants
(Figure 6). FVM expressing LQTS-CaM mutations have signif-
icantly higher twitch amplitude than cells expressing WT CaM
(Figure 8A). Notably, the mean twitch amplitude for D130G is
less than that for F142L and D96V. Similarly, diastolic Ca2+ is
higher in cells expressing the lower Ca2+-affinity CaM
mutations D96V and D130G (Figure 8B). CaM has multiple
sites of action with respect to Ca2+ homeostasis: CaM
modulation of RyR2 and Ca-CaMKII regulation of SR Ca2+
Table 2. CaM Mutants Do Not Exhibit Major Biophysical Effects on Peak INa
Voltage-Dependence of Activation Steady-State Availability
Recovery From
Inactivation
V1/2 (mV) k (mV) n V1/2 (mV) k (mV) n s (ms) n
Biophysical parameters
NaV1.5+WT CaM 45.02.1 6.60.5 9 102.93.2 8.40.2 10 10.91.3 6
NaV1.5+CaM-D130G 43.12.3 6.60.5 11 98.51.7 8.10.1 10 8.81.1 8
NaV1.5+CaM-D96V 42.61.1 7.80.3 10 105.21.0 8.70.4 13 11.20.5 11
NaV1.5+CaM-F142L 41.82.0 6.70.8 10 96.42.2 8.50.4 11 8.70.6 10
Fetal NaV1.5+WT CaM 38.41.7 7.50.5 11 103.32.2 9.71.0 9 9.10.8 10
Fetal NaV1.5+CaM-D130G 41.01.7 7.20.5 10 98.61.2 8.90.3 8 11.01.3 9
Fetal NaV1.5+CaM-D96V 35.22.1* 9.40.4‡ 9 99.11.4 13.12.3†‡ 9 12.11.6 7
Fetal NaV1.5+CaM-F142L 35.41.7* 8.30.6 6 96.31.7 8.40.3 7 8.91.4 6
All recordings were performed with high intracellular calcium concentration. CaM indicates calmodulin; WT, wild type.
*P<0.05 compared to NaV1.5+WT CaM.
†P<0.05 compared to fetal NaV1.5+WT CaM.
‡P<0.005 compared to NaV1.5+WT CaM.
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stores. Consequently, we probed the contribution of
LQTS-CaM mutation to SR Ca2+ load by assessing caffeine-
releasable Ca2+ stores (Figure 8C). The mean SR Ca2+
appears greater in LQTS-CaM mutant expressing cardiomyo-
cytes compared with cells expressing WT CaM, but the
differences did not reach statistical significance (Figure 8D).
Examination of the decay of caffeine-induced Ca2+ transient
reveals no significant difference for any of the LQTS-CaM
mutants (Figure 8E). This suggests that Na+/Ca2+ exchange
(NCX) function is not altered by LQTS-CaM mutations. These
results are consistent with the model that LQTS-CaM mutant
promoter increased trigger Ca2+ from the slowed decay of ICa,
L. NCX is the main surface membrane efflux pathway, thus
more LTCC Ca2+ influx paired with unchanged NCX-based
efflux could lead to elevated cytosolic Ca2+.
Isoproterenol Restores Entrainment for LQTS-
CaM Mutations
The LQTS-CaM mutants D96V and D130G cause abnormal
Ca2+ transients at elevated stimulation frequencies (Figures 4
and 5) and exhibit elevated cytosolic Ca2+ levels (Figure 8).
Higher Ca2+ levels could drive arrhythmogenic activity
analogous to that seen for CPVT.21 Faster pacing rates
protect against catecholamine-induced triggered activity in
CPVT models22; however, Ca2+-transient abnormalities are
exacerbated at even modestly higher rates (≥1 Hz) in FVM
expressing relatively low Ca2+-affinity LQTS-CaM mutants
(Figure 5). Isoproterenol (ISO) enhances the rate of Ca2+
reuptake to the SR in developing cardiomyocytes (Figure 9A
and 9Ai), and this effect is preserved for cardiomyocytes
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Figure 2. Long QT syndrome (LQTS) calmodulin (CaM) mutants slow CDI. A, Representative traces
recorded during a depolarization to 0 mV. The single exponential fit of a representative WT CaM current
sweep (dotted line) is illustrated for reference. The smooth line through the current traces is a single
exponential fit of the form: I(t)=Ipeak*e
t/s. B, Inactivation time constant (s) plotted as a function of voltage.
For clarity, the WT CaM data are illustrated along with each LQTS-CaM mutation plot. **P<0.01;
****P<104. CDI indicates Ca2+-dependent inactivation; WT, wild type.
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expressing LQTS-CaM mutants (Figure 9A and 9Ai). Given
the propensity of defective Ca2+ reuptake observed in D96V
and D130G-CaM expressing cardiomyocytes, we tested the
hypothesis that ISO treatment alleviates these LQTS-CaM
mutant-induced Ca2+-transient loss of entrainment. Figure 9B
shows a representative D96V-CaM-expressing cardiomyocyte.
Prior to ISO addition, a 2:1 block occurs (Figure 9B, upper
left). ISO induces a partial rescue of 1:1 entrainment
manifested as a spontaneous transition from 2:1 to 1:1
(stimulus to Ca2+ transient; Figure 9B, upper right). This type
of behavior was scored as “partial rescue” because of
spontaneous restoration and reversion of pathological Ca2+
transients. The relatively lower Ca2+ affinity D130G-CaM
exhibited alternans at 0.5 Hz pacing frequency (Figure 9C,
upper left). ISO rapidly results in full restoration of normal
Ca2+ transients in this example (Figure 9C, upper right).
Overall, ISO caused some degree of restoration of normal
Ca2+ homeostasis in 65% of cells tested. For D96V-CaM-
expressing cardiomyocytes, 9 and 2 of 17 cells showed partial
and full restoration, respectively. For D130G-CaM-expressing
cardiomyocytes, 4 and 3 of 11 cells showed partial and full
restoration, respectively. In sharp contrast, acute ISO led to
cell death in 6 of 9 CPVT-CaM mutant-expressing cardiomyo-
cytes and had no beneficial effects in the remaining cells
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Figure 3. Peak current-voltage relationships for ICa,L in fetal
ventricular cardiomyocytes. WT calmodulin data are repeated in
each panel for clarity of presentation. No significant differences
were noted in voltage dependence or amplitude. See Table 3 for
Boltzmann distribution fitted parameters. WT indicates wild type.
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Figure 4. Calmodulin (CaM) N54I does not significantly alter
Ca2+-dependent inactivation of L-type Ca2+ channel Ca2+ current.
Left, representative L-type Ca2+ channel Ca2+ current for WT CaM
and CaM-N54I superimposed. Smooth line is a single exponential
function fit. Right, pooled data for the time constant of decay of
the fitted exponential decay as a function of voltage. For Vtest
20 mV, CDI is significantly faster (P<0.05). For all other
potentials, there is no significant difference in rate of decay. WT
indicates wild type.
Table 3. Gmax, V½, and k in Fetal Cardiac Ventricular Myocytes Expressing WT or long QT CaM
Gmax V1/2 k n
WT CaM nongreen 0.1090.018 7.20.6 6.60.2 13
WT CaM green 0.0550.008* 8.80.4 6.60.2 9
WT CaM combination 0.0870.012 7.90.4 6.60.1 22
CaM-F142L 0.0590.014* 5.61.7 7.20.3 10
CaM-D96V 0.0570.013 6.30.5 6.10.3 6
CaM-D130G 0.0540.024 9.81.5 6.30.1 6
CaM indicates calmodulin; WT, wild type.
*P<0.05 compared with WT CaM nongreen.
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tested. These data suggest that slowed Ca2+ reuptake
contributes to LQTS-CaM–associated arrhythmogenesis, and
enhancing the rate of reuptake is a plausible mechanism for
ameliorating LQTS-CaM dysfunction.
Discussion
The major new finding of this study is that CaM mutants
associated with LQTS cause significantly slowed CDI of ICa,L
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Figure 5. Long QT syndrome (LQTS) CaM mutant expression induces loss of field-stimulation
entrainment in rank order with Ca2+ affinity. A, Representative Ca2+ transients for pacing frequencies
of 0.5, 1, and 2 Hz. B, Representative Ca2+ transient for a cardiomyocyte expressing D96V-CaM showing
2:1 block. The stimulus frequency is 1 Hz, and individual stimuli are denoted by vertical lines below the
Ca2+ transients. The red arrows above the Ca2+ transient show the stimuli that did not elicit a Ca2+
transient. C, Summary plot of the prevalence of escape from entrainment events in cardiomyocytes
expressing exogenous WT CaM or LQTS-CaM mutants. Higher stimulus frequency evoked a greater
prevalence of escape events in rank order with Ca2+-CaM affinity. For statistical testing, we lumped
together escape events at 2 and 3 Hz, P<104. CaM indicates calmodulin; WT, wild type.
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and alter Ca2+ homeostasis in FVM. We also excluded a major
contribution of dysregulated Na current caused by LQTS-CaM
mutations. In contrast, the CPVT-CaM mutant N54I had no
effect on CDI but disrupted Ca2+ homeostasis. We conclude
that LQTS-CaM evokes the novel mechanism of CDI slowing
to initiate the sequence of cellular physiological events
leading to ventricular arrhythmia.
This study shows a rank-order relationship between
Ca2+-CaM affinity and the propensity for abnormal Ca2+
homeostasis. This relationship holds for the 3 tested LQTS-
CaM mutants and is distinct for CPVT-CaM mutant N54I.
LQTS is driven by a prolongation of the ventricular cellular AP
duration, and AP duration is determined by the sum of ionic
conductance, principally net voltage-gated K+ channels and
LTCC. CaM prebound to LTCC confers a direct relationship
between CaM alterations of LTCC current and AP duration,
whereby increased Ca2+ influx prolongs AP duration. LQTS-
CaM mutations occur de novo in the carboxyl-terminus
(C-lobe) of CaM.2 The C-lobe of LTCC-bound CaM senses Ca2+
entry through single LTCC channel openings, and this occurs
in a restricted space where local [Ca2+] can reach levels as
high as 60 to 100 lmol/L.23,24 The LQTS-CaM mutation
F142L C-lobe Ca2+-affinity Kd is 15 lmol/L, well below the
estimated local [Ca2+], and thus may explain the relatively
subtle effects observed with F142L. The D130G Ca2+ Kd is
150 lmol/L, which is consistent with a greater propensity to
promote pathological Ca2+ transients among LQTS-CaM
mutants tested. Recent studies also quantified the LQTS-
CaM LTCC effects25 based on the conceptual framework of an
enzyme-inhibitor-like tuning of LTCC-CaM signaling.26,27 In
contrast, the CPVT-CaM mutation N54I is located on the N-
lobe and shows sensitive, near normal Ca2+ affinity.4 This
supports the contention that LQTS-CaM mutation primarily
targets LTCC, whereas CPVT-CaM leaves LTCC function
intact.
Examination of Ca2+ transients reveals mutant-CaM effects
that are not predicted by examining LTCC function alone.
LQTS-CaM slows CDI, but CaM-N54I has no effect on CDI;
however, both classes of LQTS-CaM mutations D96V, D130G,
and N54I result in abnormal Ca2+ transients. Recent work
demonstrated that CPVT-CaM, but not LQTS-CaM, induces
inappropriate SR Ca2+ release12 driven by aberrant CaM-RyR2
interactions (cf8). In the present study, we uniquely show that
the nature of the Ca2+-transient phenotype differs in cardio-
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transients. A, Representative Ca2+ transients in cardiomyocytes expressing calmodulin-N54I. B, Loss of
entrainment for frequencies ≥1 Hz; for 3 Hz, no entrainment was possible. P<104. C, Representative Ca2+
transient displaying alternans at 1 Hz. D, For 1 Hz, all calmodulin-N54I cardiomyocytes displayed abnormal
Ca2+-transient phenotypes; the majority of cells displayed alternans. P<104. WT indicates wild type.
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myocytes expressing LQTS-CaM–associated mutations D96V
and D130G compared with cells expressing CPVT-CaM
mutants. The predominant pattern of pathological Ca2+
transients exhibited by cells expressing these 2 LQTS-CaM
mutants was slowed SR Ca2+ reuptake, whereas cells
expressing the CPVT-CaM mutant N54I showed a combination
of alternans and 2:1 blockade. The latter finding is consistent
with other models of CPVT.28 Moreover, in mouse models of
CPVT, catecholamines trigger activity in the ventricular
myocardium,29–31 and the catastrophic effect of ISO on
CaM-N54I FVM is consistent with expectations of CPVT. A
dominant contributor to twitch Ca2+-transient relaxation is
phospholamban-SERCa function. In this vein, ISO is predicted
to have 2 major effects: increasing the rate of SR Ca2+
reuptake through phospholamban-SERCa signaling and
increasing Ca2+ influx by LTCC activation. Additional consid-
erations reveal the benefit of assessing Ca2+ transients as an
integrative measure of function. For example, an ISO-induced
increase of K+ conductance simultaneously acts to shorten
AP duration, blunting the time course of LTCC Ca2+ influx. ISO
is well established to speed Ca2+ transient kinetics and
increase SR Ca2+ load. If LQTS-CaM effects were limited only
WT
F1
42
L
D9
6V
D1
30
G
0.3
0.4
0.5
0.6
0.7
0.8
Twitch Decay
Ti
m
e(
s)
****
WT
F1
42
L
D9
6V
D1
30
G
0.5
1.0
1.5
2.0
F3
40
/3
80
Diastolic Ratio (1Hz)
** ****
A B
C
WT
F1
42
L
D9
6V
D1
30
G
0
5
10
15
Ti
m
e(
s)
WT
F1
42
L
D9
6V
D1
30
G
0.0
0.5
1.0
1.5
F3
40
/3
80
ED
Ca?eine Pulse Amplitude Ca?eine Pulse Decay Time
WT F142L D96V D130G
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CaM affinity. Relatively low Ca2+-affinity D96V and D130G-CaM show a significantly slower decay rate for
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2+ is not
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to slowing of CDI, then we would have expected that ISO
would not restore normal Ca2+ transients. The finding that
ISO restored normal Ca2+ transients in LQTS reveals distinc-
tions between CPVT-CaM and LQTS-CaM mutations and
highlights the unexpected contribution of augmented Ca2+
reuptake as a future therapeutic direction for LQTS-CaM
patients. Applying therapeutics involving increased SR Ca2+
reuptake has plausible future possibilities considering early
successes of the Calcium Up-regulation by Percutaneous
Administration of Gene Therapy in Cardiac Disease (CUPID)
trial.32
Study Limitations
For heterologous expression of NaV1.5 we selected 2
prominently expressed products of alternative splicing: the
canonical form expressed in adult heart and a developmen-
tally regulated splice variant that is expressed prominently in
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Figure 9. b-adrenergic stimulation speeds twitch duration and restores entrained rhythmicity in
cardiomyocytes expressing relatively low Ca2+-affinity long QT syndrome calmodulin (CaM) mutants. A,
Stimulated twitch decay (1 Hz) at baseline and following 100 nmol/L ISO. *P<0.05. Ai, Regardless of
exogenous CaM expression, the twitch decay rate was faster following ISO. Data from (A) replotted as cell-
by-cell response to ISO.**P<0.001; ***P<104; n=10 or 11. B, Representative Ca2+ transient for D96V-
CaM expressing fetal ventricular myocyte. Left panel shows 1-Hz stimulation to illustrate baseline 2:1 block.
Right panel shows an example of partial restoration of entrainment of Ca2+ transient to field stimulation.
With ISO, the 2:1 activity spontaneously reverts to 1:1 activity. n=10. C, Representative Ca2+ transient for
D130G-CaM expressing fetal ventricular myocyte. Left panel shows 0.5-Hz stimulation to illustrate baseline
alternans. Right panel shows an example of recovery of entrainment following ISO. n=10. ISO indicates
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fetal and infant heart. Evidence exists for protein expression
of both splice isoforms. Other SCN5A splice variants have
been demonstrated at the mRNA level but not at the protein
level, and their developmental regulation is uncertain. The
most straightforward interpretation of our NaV1.5 data is that
augmentation of late INa is not to the main pathophysiological
mechanism responsible for the LQTS-CaM phenotype; how-
ever, we cannot exclude that another unstudied splice variant
conspires with mutant CaM to evoke a pathological pheno-
type. In contrast, our data on Ca2+ channel modulation argues
effectively that delayed CDI is a more plausible mechanism for
LQTS associated with CaM mutations.
Relatively late development stage FVM served as a
cellular model to study the effects of LQTS-CaM–associated
mutations. These late-stage FVM express a full complement
of mature cardiomyocyte physiological responses including
Ca2+-induced Ca2+ release20,33 and b-adrenergic receptor–
mediated responses.34,35 As with any cellular system, there
are limitations. First, although the LTCC multiprotein
complex is fully functional, the same issues discussed
above for expression of various channel protein isoforms
applies. Second, this is a cellular model, and behaviors of
dispersed cells may not report native physiological
responses. Although this system allows us to use a
common background to compare the influence of CaM
mutations, it will be important to follow up studies in more
complex in vivo settings.
In summary, LQTS- and CPVT-associated CaM mutations
both disrupt Ca2+ homeostasis in murine cardiomyocytes, but
there is a sharp dichotomy in pathways leading to patholog-
ical phenotypes. LQTS-CaM mutations occurring on the C-lobe
of CaM reduce Ca2+ affinity and, consequently, cause slowing
of LTCC kinetics by attenuating CDI. In contrast, CPVT-CaM
mutant N54I has no effect on LTCC kinetics. As expected
for CPVT, b-adrenergic stimulation irreversibly overloaded
cytosolic Ca2+ but also partially restored entrainment. This
suggests a potential proof of principle for genotype-specific
treatment of “calmodulinopathies.”
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